Q Linea (Sweden) Today

QLINEA Stock  SEK 1.09  0.03  2.68%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 68

 
High
 
Low
Quite High
Q Linea is trading at 1.09 as of the 11th of December 2024, a 2.68 percent decrease since the beginning of the trading day. The stock's open price was 1.12. Q Linea has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 11th of November 2024 and ending today, the 11th of December 2024. Click here to learn more.
Q-linea AB researches, develops, manufactures, and sells instruments and disposables for infection diagnostics. Q-linea AB was founded in 2008 and is based in Uppsala, Sweden. Q Linea operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. The company has 29.21 M outstanding shares. More on Q linea AB

Moving together with QLINEA Stock

  0.93GETI-B Getinge AB serPairCorr
  0.63EKTA-B Elekta ABPairCorr
  0.84ALIF-B AddLife ABPairCorr
  0.86BIOT Biotage ABPairCorr
  0.82SYNSAM Synsam ABPairCorr

Moving against QLINEA Stock

  0.85BONEX Bonesupport HoldingPairCorr
  0.79SHB-B Svenska HandelsbankenPairCorr
  0.76ERIC-A TelefonaktiebolagetPairCorr
  0.74SHB-A Svenska HandelsbankenPairCorr
  0.59VOLV-B AB VolvoPairCorr
  0.53VOLV-A AB VolvoPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

QLINEA Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Q Linea's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Q Linea or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO PresJonas Jarvius
Business ConcentrationMedical Instruments & Supplies, Healthcare (View all Sectors)
Q linea AB (QLINEA) is traded on Stockholm Exchange in Sweden and employs 156 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 391.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Q Linea's market, we take the total number of its shares issued and multiply it by Q Linea's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Q linea AB operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 29.21 M outstanding shares. Q linea AB has accumulated about 15.09 M in cash with (255.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Q Linea Probability Of Bankruptcy
Ownership Allocation
Q Linea owns a total of 29.21 Million outstanding shares. The majority of Q linea AB outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Q linea AB to benefit from reduced commissions. Thus, institutional investors are subject to a different set of regulations than regular investors in Q Linea. Please pay attention to any change in the institutional holdings of Q linea AB as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check QLINEA Ownership Details

Q linea AB Risk Profiles

Although Q Linea's alpha and beta are two of the key measurements used to evaluate Q Linea's performance over the market, the standard measures of volatility play an important role as well.

QLINEA Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Q Linea without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Q Linea Corporate Management

Elected by the shareholders, the Q Linea's board of directors comprises two types of representatives: Q Linea inside directors who are chosen from within the company, and outside directors, selected externally and held independent of QLINEA. The board's role is to monitor Q Linea's management team and ensure that shareholders' interests are well served. Q Linea's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Q Linea's outside directors are responsible for providing unbiased perspectives on the board's policies.

Other Information on Investing in QLINEA Stock

Q Linea financial ratios help investors to determine whether QLINEA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in QLINEA with respect to the benefits of owning Q Linea security.